SavedAdd your journal

Journals / The European Research Journal / 2016 / Cilt: 2 - Sayı: 1

Efficacy of antibody levels in different post-exposure rabies vaccination programs

Cigdem Ataman HATİPOGLU
Sami KİNİKLİ
Ali Pekcan DEMİROZ
Meliha Cagla SONMEZER
Esra Kaya KİLİC
Cemal BULUT
Pages
36–41
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Identification of similar seroconversion rates suggests that the2-1-1 vaccination program may be a good alternative option to the standard vaccination program when RIG is unavailable.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Rabies is a fatal acute viral zoonotic disease causing encephalomyelitis in humans and many othermammalian animals.
📊
Key Findings & Data:In 61 (71.8%) patientsa 2-1-1 vaccine program (Zagreb regimen) was implemented, and in 24 (28.2%) patients, a 5-dose rabiesvaccine and rabies immune globulin (RIG) in a dose of 40 IU/kg (Essen regimen) was applied.
💡
Conclusion & Impact:Identification of similar seroconversion rates suggests that the2-1-1 vaccination program may be a good alternative option to the standard vaccination program when RIG is unavailable.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives. Rabies is a fatal acute viral zoonotic disease causing encephalomyelitis in humans and many othermammalian animals. Prophylaxis is vital since there is no treatment for rabies. This study was a comparisonof antibody levels in patients who were vaccinated following different vaccinationprotocols. Methods. Eightyfive patients who were included in the rabies vaccination program who presented to the vaccination center ofour clinic with the complaint of suspicious contact with rabies were included the study. In 61 (71.8%) patientsa 2-1-1 vaccine program (Zagreb regimen) was implemented, and in 24 (28.2%) patients, a 5-dose rabiesvaccine and rabies immune globulin (RIG) in a dose of 40 IU/kg (Essen regimen) was applied. Results. Inpatients on the 2-1-1 vaccine program, antibody levels on the 21stday were greater than 0.5 IU/ml in 49 (80.3%)patients. Antibody levels on the 28thday in the group that received the 5-dose rabies vaccine and rabies immuneglobulin administration was greater than 0.5 IU/ml in 17 (70.8%) patients. The difference between the twogroups of vaccination programs was not statistically significant (p=0.344). Seroconversion rates forapproximately one month after the last dose of vaccination in the serum samples were 90% and 75% in thegroups with 2-1-1 vaccination, and RIG and 5-dose vaccinations, respectively. The differences were notstatistically significant (p=0.071). Conclusions. Identification of similar seroconversion rates suggests that the2-1-1 vaccination program may be a good alternative option to the standard vaccination program when RIG is unavailable.

🔖

Cite This Article

HATİPOGLU, C. A., KİNİKLİ, S., DEMİROZ, A. P., SONMEZER, M. C., KİLİC, E. K., BULUT, C. (2022). Efficacy of antibody levels in different post-exposure rabies vaccination programs. The European Research Journal, Cilt: 2 - Sayı: 1, 36–41. https://ajindex.com/articles/597795

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Madhusudana SN, Sanjay TV, Mahendra BJ. Sudarshan MK, Narayana DHA, Giri A, et al. Comparison of safety and immunogenicity of purified chick embryo cell rabies vaccine (PCEV) and purified vero cell rabies vaccine (PVRV) using the Thai Red Cross intradermal regimen at a dose of 0.1 ML. Hum Vaccine. 2006;2(5):200-4.
  2. Bassin SL, Rupprecht CE, Bleck TP. Rhabdoviruses. In: Mandell, Doglas and Bennett's Principles and Practice of Infectious Diseases, 7th. edition. New York: Churchill Livingstone Press; 2010. 2: 249-58. Centers for Disease Control Human Rabies prevention-United States Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Suppl. 2010; 59: RR-2. Hanlon CA, Carey L. Rabies virus and other rhabdoviruses. In: Kasper DL, Fauci AS, Longo DL et al. editors. Harrison's Principles of Internal Medicine 17th edition, McGraw-Hill Press. 2008;1:811-35. Rabies Prevention and Control Guidelines of the Republic of Turkey, Ministry of Health, Ankara: General Directorate of Basic Health Services; 2005:p.13-22. World Health Organization. WHO guide for rabies pre andpost- exposure prophylaxis in humans. Available at:http://www.who.int/rabies/PEP_prophylaxis_guidelines_June10.pdf. Accessed 21 June 2013.
  3. Wasniewski M, Labbe A, Tribout L, Rieder J, Labadie A, Schereffer JL, et al. Evaluation of a rabies ELISA as an alternative method to seroneutralisation tests in the context of international trade of domestic carnivores. J Virol Methods. 2014 Jan;195:211-20.
  4. Ma X, Niezgoda M, Blanton JD, Recuenco S, Rupprecht CE. Evaluation of a new serological technique for detecting rabies virus antibodies following vaccination. Vaccine. 2012 Aug 3;30(36):5358-62.
  5. Rupprecht CE, Briggs D, Brown CM, Franka R, Katz ZL, Kerr HD, et al. Evidence for a 4-dose vaccine schedule for human rabies post- exposure prophylaxis in previously non-vaccinated individuals. Vaccine. 2009 Nov 27; 27(51):7141-8.
  6. Hu Q, Liu MQ, Zhu ZG, Zhu ZR, Lu S. Comparison of safety and immunogenicity of purified chick embryo cell vaccine using Zagreb and Essen regimens in patients with category II exposure in China. Hum Vaccin Immunother. 2014;10(6):1645-9.
  7. Chutivongse S, Wilde H, Fishbein DB, Baer GM, Hemachudha T. One-year study of the 2-1-1 intramuscular postexposure rabies vaccine regimen in 100 severely exposed Thai patients using rabies immune globulin and Vero cell rabies vaccine. Vaccine. 1991 Aug;9(8):573-6.
  8. Shantavasinkul P, Tantawichien T, Wilde H, Sawangvaree A, Kumchat A, Ruksaket N,